Difference between revisions of "Template:Antimycobacterials"
Jump to navigation
Jump to search
blackwiki>Tom (LT) m (per Template_talk:Medicine_navs#Background_colours, remove unnecessary and confusing background colours using AWB) |
blackwiki>NSH002 (tidy up) |
||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Antimycobacterials |
| − | | title = [[Antimycobacterial]]s, including [[tuberculosis treatment]] and [[leprostatic agent]]s ([[ATC code J04|J04]]) | + | | title = [[Antimycobacterial]]s, including [[tuberculosis treatment]] and [[leprostatic agent]]s ([[ATC code J04|J04]]) |
| − | | state = {{{state|autocollapse}}} | + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| − | |listclass = hlist | + | | listclass = hlist |
| − | |||
| − | + | | group1 = [[Nucleic acid inhibitor]] | |
| − | + | | list1 = {{Navbox|child | |
| − | |||
| − | | group1 = [[Rifamycin]]s/< | + | | group1 = [[Rifamycin]]s/<br />[[RNA polymerase]] inhibitor |
| − | | list1 | + | | list1 = |
* [[Rifampicin]]<sup>#</sup> | * [[Rifampicin]]<sup>#</sup> | ||
* [[Rifabutin]] | * [[Rifabutin]] | ||
* [[Rifapentine]] | * [[Rifapentine]] | ||
| − | | group2 = [[Antifolate]]s/[[Dihydropteroate synthetase inhibitor|DSI]] | + | | group2 = [[Antifolate]]s/[[Dihydropteroate synthetase inhibitor|DSI]] |
| − | | list2 | + | | list2 = |
* [[Dapsone]]<sup>#</sup> | * [[Dapsone]]<sup>#</sup> | ||
* [[Acedapsone]] | * [[Acedapsone]] | ||
* [[Aldesulfone sodium]] | * [[Aldesulfone sodium]] | ||
| − | | group3 = ASA | + | | group3 = ASA |
| − | | list3 | + | | list3 = |
* ''[[4-Aminosalicylic acid]]''<sup>#</sup> ([[Calcium aminosalicylate]] | * ''[[4-Aminosalicylic acid]]''<sup>#</sup> ([[Calcium aminosalicylate]] | ||
* [[Sodium aminosalicylate]]) | * [[Sodium aminosalicylate]]) | ||
| − | }} | + | }} |
| + | | group2 = [[Protein synthesis inhibitor]] | ||
| + | | list2 = {{Navbox|child | ||
| − | + | | group1 = [[Aminoglycoside]]s | |
| − | + | | list1 = | |
| − | |||
| − | |||
| − | | group1 = [[Aminoglycoside]]s | ||
| − | | list1 | ||
* [[Amikacin]]<sup>#</sup> | * [[Amikacin]]<sup>#</sup> | ||
* [[Capreomycin]]<sup>#</sup> | * [[Capreomycin]]<sup>#</sup> | ||
| Line 41: | Line 37: | ||
* [[Streptomycin]]<sup>#</sup> | * [[Streptomycin]]<sup>#</sup> | ||
| − | + | | group2 = [[2-Oxazolidone|Oxazolidone]] | |
| − | | group2 = [[2-Oxazolidone|Oxazolidone]] | + | | list2 = |
| − | | list2 | ||
* [[Linezolid]] | * [[Linezolid]] | ||
| + | }} | ||
| − | + | | group3 = [[Cell envelope antibiotic]] | |
| − | + | | list3 = {{Navbox|child | |
| − | |||
| − | |||
| − | | group1 = [[Peptidoglycan]] layer | + | | group1 = [[Peptidoglycan]] layer |
| − | | list1 | + | | list1 = |
* [[Alanine]] analogue: [[Cycloserine]]<sup>#</sup> | * [[Alanine]] analogue: [[Cycloserine]]<sup>#</sup> | ||
| − | + | | group2 = [[Arabinogalactan]] layer | |
| − | + | | list2 = | |
| − | * [[Ethylenediamine]]/[[arabinosyltransferase]] inhibitor: [[Ethambutol]]<sup>#</sup | + | * [[Ethylenediamine]]/[[arabinosyltransferase]] inhibitor: [[Ethambutol]]<sup>#</sup> |
| − | [[SQ109]]<sup>†</sup> | + | * [[SQ109]]<sup>†</sup> |
| − | + | | group3 = [[Mycolic acid]] layer | |
| − | + | | list3 = | |
| − | * [[Hydrazide]]s/[[mycolic acid]] synth. inhibition: [[Isoniazid]]<sup>#</sup | + | * [[Hydrazide]]s/[[mycolic acid]] synth. inhibition: [[Isoniazid]]<sup>#</sup> |
| − | *[[Thiocarbamide]]s: [[Ethionamide]]<sup>#</sup> | + | * [[Thiocarbamide]]s: [[Ethionamide]]<sup>#</sup> |
* [[Prothionamide]] | * [[Prothionamide]] | ||
* [[Thiocarlide]] | * [[Thiocarlide]] | ||
| − | }} | + | }} |
| − | + | | group4 = Other/unknown | |
| − | + | | list4 = | |
* ''[[Phenazine]]'' ([[Clofazimine]])<sup>#</sup> | * ''[[Phenazine]]'' ([[Clofazimine]])<sup>#</sup> | ||
* ''[[Pyrazine]]'' ([[Pyrazinamide]]<sup>#</sup>, [[Morinamide]]) | * ''[[Pyrazine]]'' ([[Pyrazinamide]]<sup>#</sup>, [[Morinamide]]) | ||
| Line 80: | Line 74: | ||
* ''[[Metronidazole]]'' (''[[delamanid]]'') | * ''[[Metronidazole]]'' (''[[delamanid]]'') | ||
| − | + | | group5 = Combinations | |
| − | + | | list5 = | |
* [[Rifampicin/isoniazid/pyrazinamide]] | * [[Rifampicin/isoniazid/pyrazinamide]] | ||
| − | | belowstyle = background: transparent; padding: 0px; | + | | belowstyle = background: transparent; padding: 0px; |
| − | | below = {{PharmNavFootnote}}{{Bacteria navs}} | + | | below = {{PharmNavFootnote}}{{Bacteria navs}} |
}}<noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
| − | [[Category: | + | [[Category:Drug templates by ATC]] |
| − | |||
</noinclude> | </noinclude> | ||
Revision as of 18:36, 1 April 2015
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Antimycobacterials|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Antimycobacterials|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Antimycobacterials|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.